1. ACC: Novel Stents May be More Effective
(Radiology Conferences/Conference News)

... or MI and P=NS for definite stent thrombosis). The new stent also had the lowest two-year rates for target vessel revascularization (7.7% versus 10.7% Cypher and 14.3% Endeavor), and for binary restenosis ...

2. Interim Results from COBEST Clinical Study
(Radiology Conferences/VIVA 2009)

... pressures, and symptomatic patient outcomes based on the type of lesion classification, target vessel revascularization, as well as patient relief at each time interval out to 18 months. The interim data ...

3. VIVA 2009 Late-Breaking Trials
(Radiology Conferences/VIVA 2009)

... both groups. In the ITT patients, 16.4% had site-reported serious adverse events. There were no unanticipated adverse device effects. At 30 days, the restenosis rate was 1.6%, and the target lesion revascularization ...

4. Cardiogenesis Announces Successful Symposium at the TCT Meeting
(Communities/Cardiac Vasculature)

Cardiogenesis Corporation announces that it sponsored an educational symposium in conjunction at TCT meeting Cardiogenesis Corporation, a market leader in laser transmyocardial revascularization (TMR), ...

5. St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis Management Solutions at TCT 2009
(Company News/St Jude Medical, Inc.)

... whose treatment was guided only by angiography. Notably, there was a statistically significant difference of 28% in Major Adverse Cardiac Events (MACE) such as death, myocardial infarction and repeat revascularization; ...

6. Volcano Corporation Announces Schedule of Events for the 2009 TCT Conference
(Company News/Volcano)

... M.D., Gary S. Mintz, M.D., Gregg W. Stone, M.D. and Alexandra Lansky, M.D. The second session, entitled, "Ischemia, FFR and Optimal Revascularization," will include presentations by Gregg W. Stone, M.D., ...

7. PLC Medical Systems to Demonstrate RenalGuard at TCT 2009, Building on Success at ESC 2009
(Company News/PLC Systems Inc.)

... the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. Additional company information can be found at www.plcmed.com. ...

8. PLC Systems Announces Distribution Agreement for RenalGuard in Bangladesh and Pakistan
(Company News/PLC Systems Inc.)

... System, which cardiac surgeons use to perform CO(2) transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, RenalGuard, is approved for sale in the EU as a ...

9. Report on Medical Imaging Markets : MRI (Magnetic Resonance Imaging) and Ultrasound
(Communities/Ultrasound)

... management in cases of myocardial infarction in which revascularization is being considered. Where previously a full cardiac workup would have required visits to both echo cardiology and nuclear medicine, ...

10. VIVA 2009
(Radiology Conferences/VIVA 2009)

... complications following endovascular and surgical revascularization and develop management strategies for these complications. * Analyze areas in need of clinical and translational research to advance ...

11. PLC Systems Announces Appointment of Louis Brenner, M.D. to Board of Directors
(Company News/PLC Systems Inc.)

... the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, RenalGuard, is approved for sale ...

12. SPECT MPI with Cardiolite Used in BARI 2D Study to Evaluate Type 2 Diabetes and Coronary Artery Disease Treatment Strategies
(Company News/Lantheus Medical Imaging, Inc)

... type 2 diabetes and coronary artery disease. The results of this study, known as The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D), will be presented by the University of Pittsburgh ...

13. PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
(Company News/PLC Systems Inc.)

... transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, RenalGuard, is approved for sale in the EU as a general fluid balancing device. Additional company ...

14. PLC Systems Announces First Distribution Agreement in Spain for RenalGuard(R)
(Company News/PLC Systems Inc.)

... CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, RenalGuard, is approved for sale in the EU as a general fluid balancing device. Additional company ...

15. Cardiac Imaging Highlighted at Biennial ICNC-9
(Communities/Cardiac Vasculature)

... in the area," says Professor Juhani Knuuti, Co-Chair of the meeting. "Cardiac imagining is the key for decision-making in cardiology, permitting resources, such as medications and coronary revascularization, ...

16. RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009
(Company News/PLC Systems Inc.)

... Massachusetts, PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, ...

17. PLC Systems to Host Fourth Quarter Conference Call on March 12, 2009
(Company News/PLC Systems Inc.)

... for the cardiac and vascular markets. Headquartered in Franklin, Massachusetts, PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) ...

18. Coronary calcification predicts future cardiac events in asymptomatic subjects
(Communities/Cardiac Vasculature)

... annualized rates for all events, coronary revascularization, MI, and cardiac death. The investigators also compared the results with risk models based on conventional risk factor stratification: the ...

19. Iso-Osmolar x-ray dye falters in PCI study
(Modalities/Radiology )

... In addition, it made no difference in the need for dialysis or in the length of hospital stay, according to the Contrast Media and Nephrotoxicity Following Coronary Revascularization by Angioplasty (CONTRAST) ...

20. Stanford analysis shows little difference in risk rates for angioplasty, bypass procedures
(Imported/Imported)

...  between the two procedures. Hlatky said this was surprising, given the 1995 results from the Bypass Angioplasty Revascularization Investigation by the National Institutes of Health. The BARI study ...